Already have an ACS ID? Log in
Renew your membership, and continue to enjoy these benefits.
Already an ACS Member? Log in here
Choose the membership that is right for you. Discounts will be applied automatically at checkout.
Enjoy these benefits no matter which membership you pick.
Most Popular in Business
The Dutch company Micreos has raised about $34 million to further develop enzyme-based antibiotics called endolysins. The enzymes are normally made by bacteriophages, viruses that selectively kill specific strains of bacteria. The company already offers a nonprescription skin-care product called Gladskin containing endolysins that specifically kill the bacteria Staphylococcus aureus to treat conditions such as acne and eczema. Micreos plans to begin selling Gladskin in the US this year.
This article has been sent to the following recipient: